Pacifico Biolabs
Pacifico Biolabs specialises in the cultivation of microorganisms, focusing on developing ‘whole-muscle’ structures as sustainable and nutritious alternatives to traditional fish products.
Pacifico Biolabs has raised €10M across 2 funding rounds from 7 investors, most recently a Series A round in May 2026. Based in Berlin, Germany; active in Foodtech. Data as of 28 Oct 2026.
Berlin, Germanywww.pacificobiolabs.com ↗
Total raised
€10M
€10,064,636
Funding rounds
2
Investors
7
distinct backers
Active since
2024-02
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDPacifico Biolabs — funding by year — interactive chart.
Data table
| Pacifico Biolabs — funding by year | |
|---|---|
| 2024 | €3.1M |
| 2026 | €7.0M |
Signals
High confidenceRaise-next likelihood33
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-27 | Series A | €7.0M | FoodLabs,regional brewery partner,Simon Capital,Sprout & About Ventures,Stray Dog Capital,Technologiegründerfonds Sachsen (TGFS) | View deal → |
| 2024-02-16 | Pre-Seed | €3.1M | Exceptional Ventures,FoodLabs,Simon Capital,Sprout & About Ventures | View deal → |